Table 2: Characteristics of patients with chronic hepatitis B related in response to NA treatment.

Variables N-responder (n=20) Responder (n=77) P values OR (CI 95%)
Mean age, year 40.05(8.69) 38.59(9.15) 0.69 1.02(0.96-1.07)
Male (%) 14(70) 56(72.7) 0.8 0.87(0.29-2.57)
Baseline HBV DNA
(IU)
2.9x105 ± 8.92x105 7.1x105 ± 3.53x105 0.64 1(1-1)
BMI 29.8±3.7 30.25±4.8 0.38 0.97(0.87-1.09)
Coffee drink(yes/no) 12/8 45/32 0.9 0.93(0.34-2.56)
Smoking (yes/no) 9/11 36/41 0.89 1.07(0.4-2.8)
Alcohol consumption(yes/no) 3/17 8/69 0.56 0.65(0.16-2.74)
Residence (Rural/Urban) 11/9 50/27 0.41 0.66(0.24-1.79)
Hb(g/dl) 11.8±1.67 11.81±1.68 0.96 0.99(0.74-1.34)
ALT(IU) 71.6±27.75 81.54±29.73 0.17 0.98(0.96-1)
kAST(IU) 65.15±32.19 66.85±31.29 0.82 0.99(0.98-1.01)
Total Bilirubin 1.07±0.43 1.1±0.38 0.73 0.79(0.22-2.9)
INR 1.2±0.34 10.14±0.27 0.1 3.5(0.72-17.5)
ALB (g/L) 3.7±0.58 3.6±0.6 0.73 1.15(0.5-2.6)
S. Creatinine(mg/dl) 1.1±0.42 1±0.34 0.28 2(0.56-7.23)
Glucose level(mg/dl) 94.45±12.37 97.4±11.93 0.32 0.97(0.93-1.02)
AFP (ng/mL) 10.1±5.16 11.18±5.23 0.41 0.95(0.85-1.06)
U/S(Normal/Bright/Coarse) 0/13/7 8/34/35 0.21 1.9(0.68-5.3)